CHU Hopital nord (Lucien Neuwirth)
- Address
- 108 bis av Albert Raimond, 42271 Saint Priest En Jarez, France
Hemic and Lymphatic Diseases
Research at CHU Hopital nord (Lucien Neuwirth) targets chronic phase chronic myelogenous leukemia, aiming to enhance deep molecular remission through innovative drug pairings.
- Combination strategies with tyrosine kinase inhibitors
- Adaptive trial designs to accelerate response evaluation
- Biomarker-driven patient selection
The goal is to increase the proportion of patients achieving a sustained MR4.5, thereby improving long‑term survival prospects.
Male Urogenital Diseases
Studies focus on castration‑resistant prostate cancer, testing whether common cardiovascular medicines can extend overall survival in advanced disease.
- Repurposing of established drugs for oncology
- Overall survival as a primary clinical endpoint
- Integration of metabolic health considerations in cancer care
By exploring these agents, researchers hope to provide a low‑toxicity option that complements existing prostate cancer therapies.
Neoplasms
The site’s oncology program spans multiple tumor types, including both blood and solid cancers, with an emphasis on evaluating novel therapeutic combinations.
- Multi‑modal treatment regimens
- Real‑world outcome measures
- Collaborative research across hematology and urology specialties
The overarching aim is to identify strategies that boost efficacy while maintaining patient quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Centre Hospitalier De Versailles1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU Hopital nord (Lucien Neuwirth)
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pioglitazone and Avelumab in Combination with Tyrosine Kinase Inhibitors for Chronic Phase Chronic Myelogenous Leukemia in Cytogenetic Response | Centre Hospitalier De Versailles | Phase II | Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2019-06-26 | 2019-06-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.